HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward Faught Selected Research

ezogabine (retigabine)

10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
10/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
7/2018Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
5/2011Ezogabine: a new angle on potassium gates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward Faught Research Topics

Disease

51Epilepsy (Aura)
01/2022 - 12/2002
29Seizures (Absence Seizure)
12/2021 - 01/2003
8Drug Resistant Epilepsy
01/2022 - 10/2006
8Partial Epilepsies (Epilepsy, Partial)
11/2021 - 09/2005
7Generalized Epilepsy
01/2019 - 01/2003
3Status Epilepticus (Complex Partial Status Epilepticus)
09/2020 - 10/2017
3Infantile Spasms (West Syndrome)
03/2016 - 12/2011
2Psychotic Disorders (Schizoaffective Disorder)
01/2020 - 10/2003
2Headache (Headaches)
01/2019 - 12/2017
2Absence Epilepsy (Childhood Absence Epilepsy)
10/2018 - 07/2018
2Juvenile Myoclonic Epilepsy
10/2018 - 07/2018
2Lennox Gastaut Syndrome
10/2018 - 10/2006
2Memory Disorders (Memory Loss)
08/2008 - 12/2002
2Hippocampal Sclerosis
05/2005 - 12/2002
1Eclampsia
09/2020
1Liver Diseases (Liver Disease)
01/2020
1Diabetes Mellitus
01/2020
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020
1Chronic Renal Insufficiency
01/2020
1Dissociative Disorders (Fugue)
01/2019
1Migraine Disorders (Migraine)
01/2019
1Mood Disorders (Mood Disorder)
01/2019
1Dizziness (Lightheadedness)
12/2017
1Heart Diseases (Heart Disease)
12/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2017
1Neuralgia (Stump Neuralgia)
12/2017
1Nausea
12/2017
1Idiopathic Generalized Epilepsy
02/2016
1Craniocerebral Trauma (Head Injury)
10/2012
1Brain Diseases (Brain Disorder)
07/2009
1Hyperammonemia
07/2009
1Brain Neoplasms (Brain Tumor)
08/2008
1Febrile Seizures (Febrile Seizure)
08/2006
1Alcoholism (Alcohol Abuse)
02/2005
1Kidney Calculi (Kidney Stone)
12/2004
1Atrophy
09/2003
1Temporal Lobe Epilepsy
09/2003

Drug/Important Bio-Agent (IBA)

31Anticonvulsants (Antiepileptic Drugs)IBA
01/2021 - 12/2002
11Pharmaceutical PreparationsIBA
11/2021 - 02/2005
8LacosamideFDA Link
12/2021 - 03/2012
7perampanelIBA
12/2021 - 10/2017
7Lamotrigine (Lamictal)FDA LinkGeneric
01/2019 - 01/2003
7Topiramate (Topamax)FDA LinkGeneric
01/2019 - 12/2007
7VigabatrinFDA Link
10/2018 - 12/2011
6Levetiracetam (Keppra)FDA LinkGeneric
11/2019 - 07/2018
5Valproic Acid (Depakote)FDA LinkGeneric
01/2019 - 01/2003
5Oxcarbazepine (Trileptal)FDA LinkGeneric
01/2019 - 07/2018
5ezogabine (retigabine)IBA
10/2018 - 05/2011
5Zonisamide (Zonegran)FDA LinkGeneric
10/2018 - 12/2004
4eslicarbazepineIBA
10/2018 - 07/2018
4Clobazam (HR 376)IBA
10/2018 - 07/2018
4Pregabalin (Lyrica)FDA Link
10/2018 - 07/2018
4rufinamideFDA Link
10/2018 - 07/2018
3Ethosuximide (Zarontin)FDA LinkGeneric
10/2018 - 01/2003
3Felbamate (Felbatol)FDA Link
10/2018 - 10/2006
2Phenytoin (Dilantin)FDA LinkGeneric
01/2019 - 10/2010
2Tiagabine (Gabitril)FDA Link
10/2018 - 07/2018
2Gabapentin (Neurontin)FDA LinkGeneric
10/2018 - 07/2018
2Indicators and Reagents (Reagents)IBA
01/2017 - 01/2017
2EnzymesIBA
01/2017 - 12/2007
2Deoxyglucose (2 Deoxy D glucose)IBA
07/2008 - 07/2008
1Nasal SpraysIBA
01/2022
1Diazepam (Valium)FDA LinkGeneric
01/2022
1Natalizumab (Tysabri)FDA Link
11/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2020
1BenzodiazepinesIBA
09/2020
1Adrenocorticotropic Hormone (ACTH)FDA Link
09/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2020
1Pyridoxine (Pyridoxin)FDA LinkGeneric
09/2020
1Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
09/2020
1CholesterolIBA
12/2017
1Immunoglobulin E (IgE)IBA
02/2016
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2014
1selurampanelIBA
01/2014
1Kainic Acid Receptors (Kainate Receptor)IBA
01/2014
1TOPSIBA
11/2012
1Drug CombinationsIBA
09/2009
1Transaminases (Aminotransferases)IBA
07/2009
1Galantamine (Galanthamine)FDA LinkGeneric
08/2008
1Cholinesterase Inhibitors (Anticholinesterases)IBA
02/2006
1phenyl-2-aminoethyl sulfide (PAES)IBA
10/2003

Therapy/Procedure

18Therapeutics
01/2022 - 01/2003
3Anterior Temporal Lobectomy
05/2005 - 12/2002
2Length of Stay
01/2020 - 10/2012
2Vagus Nerve Stimulation
09/2012 - 10/2011
1Lasers (Laser)
01/2021
1Laser Therapy (Surgery, Laser)
01/2021
1Patient Readmission
01/2020
1Aftercare (After-Treatment)
11/2019
1Treatment Delay
01/2019
1Wearable Electronic Devices
11/2017
1Drug Therapy (Chemotherapy)
05/2012
1Intravenous Administration
07/2009
1Electrodes (Electrode)
06/2009
1Implanted Electrodes
06/2009